35 results on '"Canales-Ochoa, Nalia"'
Search Results
2. COVID-19 Impacts the Mental Health and Speech Function in Spinocerebellar Ataxia Type 2: Evidences from a Follow-Up Study
3. Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale
4. Impacts of the COVID-19 Pandemic on the Mental Health and Motor Deficits in Cuban Patients with Cerebellar Ataxias
5. One‑carbon metabolism factor MTHFR variant is associated with saccade latency in Spinocerebellar Ataxia type 2
6. Structural Brain Correlates of Sleep Microstructure in Spinocerebellar Ataxia Type 2 and its role on clinical phenotype
7. Early corticospinal tract damage in prodromal SCA2 revealed by EEG-EMG and EMG-EMG coherence
8. Insights into cognitive decline in spinocerebellar Ataxia type 2: a P300 event-related brain potential study
9. Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2
10. Executive deficit in spinocerebellar ataxia type 2 is related to expanded CAG repeats: Evidence from antisaccadic eye movements
11. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study
12. Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study
13. Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions
14. Comprehensive Study of Early Features in Spinocerebellar Ataxia 2: Delineating the Prodromal Stage of the Disease
15. Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials
16. Progression markers of Spinocerebellar Ataxia 2. A twenty years neurophysiological follow up study
17. Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale
18. Lisuride Reduces Involuntary Periodic Leg Movements in Spinocerebellar Ataxia Type 2 Patients
19. Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
20. Weight loss is correlated with disease severity in Spinocerebellar ataxia type 2: a cross-sectional cohort study.
21. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2
22. Weight loss is correlated with disease severity in Spinocerebellar ataxia type 2: a cross-sectional cohort study
23. Involvement of the Auditory Pathway in Spinocerebellar Ataxia Type 7
24. Involvement of the Auditory Pathway in Spinocerebellar Ataxia Type 7.
25. Sleep spindles and K-complex activities are decreased in spinocerebellar ataxia type 2: relationship to memory and motor performances
26. Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients.
27. Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial
28. Heritability of saccadic eye movements in spinocerebellar ataxia type 2: insights into an endophenotype marker
29. Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2
30. Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease
31. Caracterización integral de la ataxia espinocerebelosa 2 en Cuba y su aplicación en proyectos de intervención
32. Sleep Disorders in Spinocerebellar Ataxia Type 2 Patients
33. Uncommon features in Cuban families affected with Friedreich ataxia
34. Electroneurografía de nervios craneales en ataxia espinocerebelosa tipo 2
35. Patrón electromiográfico en enfermos y portadores asintomáticos de la mutación SCA2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.